Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS: OTLC · Delayed Price · USD
0.0388
-0.0011 (-2.88%)
May 1, 2024, 11:49 AM EDT - Market closed
Oncotelic Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1992 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 0.19 | 0.24 | 0.57 | 0.47 | 0.08 | 0.63 | 1.12 | 3.54 | 27.29 | 30.03 | Upgrade
|
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.51 | 0 | 0 | Upgrade
|
Cash & Cash Equivalents | 0.19 | 0.24 | 0.57 | 0.47 | 0.08 | 0.63 | 1.12 | 12.05 | 27.29 | 30.03 | Upgrade
|
Cash Growth | -21.14% | -57.55% | 19.99% | 478.33% | -86.97% | -43.59% | -90.74% | -55.85% | -9.14% | 328.71% | Upgrade
|
Receivables | 0.02 | 0.02 | 0.02 | 0.02 | 0.15 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Inventory | 0 | 0.02 | 0.02 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Current Assets | 0.06 | 0.02 | 0.02 | 0.1 | 0.04 | 0.17 | 0.02 | 2.02 | 0.11 | 0.32 | Upgrade
|
Total Current Assets | 0.27 | 0.3 | 0.63 | 0.62 | 0.27 | 0.8 | 1.14 | 14.07 | 27.39 | 30.35 | Upgrade
|
Property, Plant & Equipment | 0 | 0 | 0 | 0.01 | 0.05 | 0 | 0 | 0.01 | 0.03 | 0.04 | Upgrade
|
Long-Term Investments | 22.65 | 22.64 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Goodwill | 5.99 | 12.07 | 21.06 | 21.06 | 21.06 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Intangible Assets | 1.1 | 1.1 | 1.92 | 1.97 | 2.3 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Long-Term Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0.03 | 0.03 | 0.04 | Upgrade
|
Total Long-Term Assets | 29.74 | 35.81 | 22.99 | 23.05 | 23.41 | 0 | 0.04 | 0.04 | 0.06 | 0.07 | Upgrade
|
Total Assets | 30.01 | 36.12 | 23.61 | 23.66 | 23.68 | 0.8 | 1.17 | 14.11 | 27.45 | 30.42 | Upgrade
|
Accounts Payable | 2 | 1.74 | 1.93 | 1.94 | 1.79 | 0.92 | 0.79 | 0.31 | 0.29 | 0.34 | Upgrade
|
Deferred Revenue | 0 | 0 | 1.57 | 1.19 | 0.86 | 0 | 0 | 0 | 0 | 0.02 | Upgrade
|
Current Debt | 11.1 | 11.26 | 8.99 | 5.43 | 1.5 | 0 | 0 | 0 | 0 | 1.06 | Upgrade
|
Other Current Liabilities | 3.41 | 3.93 | 2.97 | 2.63 | 2.63 | 0.25 | 0.86 | 1.3 | 1.82 | 0.01 | Upgrade
|
Total Current Liabilities | 16.5 | 16.92 | 15.45 | 11.18 | 6.78 | 1.16 | 1.65 | 1.61 | 2.1 | 1.42 | Upgrade
|
Long-Term Debt | 1.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Long-Term Liabilities | -0 | 12.99 | 202.76 | 708.95 | 0 | 0.92 | 0.79 | 0.31 | 0.29 | 0.36 | Upgrade
|
Total Long-Term Liabilities | 1.9 | 12.99 | 202.76 | 708.95 | 0 | 0.92 | 0.79 | 0.31 | 0.29 | 0.36 | Upgrade
|
Total Liabilities | 18.4 | 16.92 | 15.45 | 11.18 | 6.78 | 1.16 | 1.65 | 1.61 | 2.1 | 1.42 | Upgrade
|
Total Debt | 13 | 11.26 | 8.99 | 5.43 | 1.5 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Debt Growth | 15.46% | 25.17% | 65.63% | 261.65% | - | - | - | - | - | - | Upgrade
|
Common Stock | 3.99 | 3.92 | 3.75 | 0.91 | 0.84 | 0.41 | 0.27 | 0.27 | 0.27 | 0.21 | Upgrade
|
Retained Earnings | -33.52 | -25.93 | -31.02 | -21.63 | -12.13 | -295.01 | -292.28 | -278.46 | -264.81 | -251.16 | Upgrade
|
Comprehensive Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Shareholders' Equity | 12.13 | 19.41 | 7.96 | 11.77 | 16.9 | -0.36 | -0.48 | 12.5 | 25.35 | 29 | Upgrade
|
Total Liabilities and Equity | 30.01 | 36.12 | 23.61 | 23.66 | 23.68 | 0.8 | 1.17 | 14.11 | 27.45 | 30.42 | Upgrade
|
Net Cash / Debt | -12.81 | -11.02 | -8.42 | -4.96 | -1.42 | 0.63 | 1.12 | 12.05 | 27.29 | 30.03 | Upgrade
|
Net Cash / Debt Growth | - | - | - | - | - | -43.59% | -90.74% | -55.85% | -9.14% | 328.71% | Upgrade
|
Net Cash Per Share | -0.03 | -0.02 | -0.03 | -0.06 | -0.02 | 0.02 | 0.04 | 0.45 | 1.08 | 1.77 | Upgrade
|
Working Capital | -16.23 | -16.62 | -14.83 | -10.57 | -6.51 | -0.36 | -0.51 | 12.46 | 25.29 | 28.93 | Upgrade
|
Book Value Per Share | 0.03 | 0.05 | 0.03 | 0.13 | 0.28 | -0.01 | -0.02 | 0.47 | 1.01 | 1.71 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.